The Italian fintech Workinvoice, together with the software house Passepartout, launches the invoice advance integrated in the management software. The service is aimed at corporations with a turnover of more than $1.18 million (€1 million) which want to obtain immediate liquidity without constraints and only for certain credits, in a flexible and fast way.
By choosing from your management software which invoices to sell you can get 90% of the credit amount in just 48 hours from the operation, without opening a current account, without guarantees, and through a simple online expert. The credit transfer made with the Workinvoice platform is always without recourse and streamlines the administrative work of the company because it allows you to not have to monitor customer payments.
In fact, invoice trading allows companies to assign outstanding trade receivables to qualified institutional investors. The mechanism is simple and transparent: companies upload their invoices to be collected in a marketplace, where investors assess which receivables to collect.
To assign a receivable, a variable commission is required based on the maturity of the commercial security. On the other hand, the buyer of the security is attributed a discount rate, a market remuneration as a percentage of the credit, defined at auction starting from the maximum rate indicated by the client.
In 2019, the amount intermediated by invoice financing platforms reached $1.32 billion (€1.12 billion).
Passepartout is a dynamic and modern software house that has been developing management software for over 30 years and now boasts over 80,000 users. The solutions it offers are characterized by a high degree of customization.
Find more details about the service of invoice trading launched by Workinvoice and Passepartout and read the latest financial headlines with the Born2Invest mobile app.
Workinvoice – the first operational platform in invoice financing in Italy
Founded at the end of 2013 by Matteo Tarroni, Ettore Decio and Fabio Bolognini and active since 2015, Workinvoice was the first platform to become operational in the invoice financing sector in Italy. In March 2019 the company reached the break-even point.
In September 2018 the Crif Group bought 10% of Workinvoice and at the same time launched CribisCash, the first example of the evolution of fintech towards partnerships with industrial players that have the necessary resources to make the most of the ideas, services and even business models invented by startups, allowing companies to access the collection and payment data of 1.7 million companies.
Last September, Workinvoice and Crif, with the support of PwC, as strategic and technical advisor, launched the first digital market to exchange tax credits of the super ecobonus, called Ecobonus 110%.
This month, Workinvoice and SME service provider DocuMI launched the digital invoice advance service AnticipaMI
The service was born from the integration between fintech and YouDOX, the electronic invoicing and storage platform in accordance with DocuMI chosen by over 275,000 Italian companies.
AnticipaMI provides companies with an integrated electronic invoicing, management and credit advance solution in a single dashboard. Companies will thus be able to take advantage of an extremely streamlined and simple commercial credit transfer process: once the invoice to be transferred has been selected, and the debtors and credits analyzed to define the collectability and certainty of the credit, it will be transferred to institutional investors and the company will obtain 90% of the face value of the credit in 48 hours.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Citi Announced a $6 Million Loan to Sempli for SME financing
The credit granted by Citi was given in partnership with high-impact investors and multilateral development organizations. They all seek to...
How Will the Price of Ripple and Cardano Develop in the Next Few Days
The BOLL indicator shows no specific pattern and denotes the support price of $0.4969 and the resistance price of $0.5059,...
RADEEF: a 182 Million Dirham Plan to Combat Flooding in Morocco
RADEEF is also planning major expansion projects. Firstly, it plans to launch work on extending the wastewater treatment plant. The...
How Institutional Investors Feel About Impact Investing
Investors continue to face greenwashing when implementing impact investing. Among their key concerns are misleading or exaggerated impact claims (60%),...
Biotech1 week ago
Vertex Obtains EMA Validation to Expand Indications for Kaftrio
Crowdfunding2 weeks ago
58 Crowdinvesting Platforms Authorized Under the New Regulation in Europe
Biotech5 days ago
Novo Nordisk Plans to Open a Tech Headquarters in Spain
Africa2 weeks ago
Morocco’s Bank Liquidity Deficit Seems to Stabilize